Patent · US Active

Methods of using antibodies to human IL-13bc for inhibiting IL-13 binding

US7674591B2 · kind B2 · utility

4Cited by
3References
31Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 27, 2006
Grant dateMar 9, 2010
Priority date
Expiry dateJul 13, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Polynucleotides encoding the IL-13 receptor and fragments thereof are disclosed. IL-13 receptor proteins, methods for their production, inhibitors of binding of IL-13 and its receptor and methods for their identification are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.